NASDAQ •
Consumer Defensive •
Packaged Foods •
Quote as of 08/07/2026 16:00
Company Profile
IndustryPackaged Foods
SectorConsumer Defensive
ExchangeNASDAQ
Market Capitalization69 mln
Float10.50 mln
Earnings Date08/17/2026
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
0.31
Highly suspicious
Relative Strength
19
/ 100
Significantly lagging
Debt / Equity
-1.17
Negative equity
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Clene Inc. is a Salt Lake City-based pharmaceutical company developing a range of treatments built around its proprietary nanoparticle technology. Its primary focus is CNM-Au8, a gold nanoparticle compound that has been tested across multiple clinical trials targeting neurological conditions such as ALS, Multiple Sclerosis, and Parkinson's Disease. The company is also working on silver and zinc-based compounds aimed at fighting infections and supporting wound recovery. Alongside its drug development work, Clene sells a small portfolio of dietary supplements containing low concentrations of gold, silver, and zinc.
